Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
暂无分享,去创建一个
A. Voss | H. Katus | B. Meder | E. Giannitsis | Christian Galuschky | L. Frankenstein | D. Lossnitzer | F. André | S. Buss | J. Franke | H. Steen | P. Ehlermann | G. Korosoglou | S. Lehrke | K. Breuninger | T. Taeger
[1] Luigi P Badano,et al. EACVI-ASE-industry initiative to standardize deformation imaging: a brief update from the co-chairs. , 2013, European heart journal cardiovascular Imaging.
[2] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[3] D. Bluemke,et al. Prognostic value of myocardial circumferential strain for incident heart failure and cardiovascular events in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis. , 2013, European heart journal.
[4] Scott D Flamm,et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing , 2013, Journal of Cardiovascular Magnetic Resonance.
[5] Tevfik F Ismail,et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.
[6] Andreas Schuster,et al. The intra-observer reproducibility of cardiovascular magnetic resonance myocardial feature tracking strain assessment is independent of field strength. , 2013, European journal of radiology.
[7] Harald Becher,et al. Global and regional left ventricular myocardial deformation measures by magnetic resonance feature tracking in healthy volunteers: comparison with tagging and relevance of gender , 2013, Journal of Cardiovascular Magnetic Resonance.
[8] James D. Thomas,et al. Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure. , 2012, Journal of the American College of Cardiology.
[9] A. Voss,et al. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. , 2012, Journal of the American College of Cardiology.
[10] Igor Klem,et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation , 2011, Journal of the American College of Cardiology.
[11] Massimo Lombardi,et al. Cost evaluation of cardiovascular magnetic resonance versus coronary angiography for the diagnostic work-up of coronary artery disease: Application of the European Cardiovascular Magnetic Resonance registry data to the German, United Kingdom, Swiss, and United States health care systems , 2012, Journal of Cardiovascular Magnetic Resonance.
[12] P. Sanders,et al. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography. , 2012, European Heart Journal.
[13] E. Nagel,et al. Cardiac magnetic resonance myocardial feature tracking detects quantitative wall motion during dobutamine stress , 2012, Journal of Cardiovascular Magnetic Resonance.
[14] P. Poole‐Wilson,et al. Role of Cardiovascular Magnetic Resonance as a Gatekeeper to Invasive Coronary Angiography in Patients Presenting With Heart Failure of Unknown Etiology , 2011, Circulation.
[15] N. Osman,et al. Strain-encoded cardiac magnetic resonance during high-dose dobutamine stress testing for the estimation of cardiac outcomes. Comparison to clinical parameters and conventional wall motion readings , 2011, Journal of the American College of Cardiology.
[16] H. Katus,et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy , 2010, Heart.
[17] Robert Fleck,et al. Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. , 2010, JACC. Cardiovascular imaging.
[18] J. Francis,et al. The role of cardiovascular magnetic resonance imaging in heart failure. , 2009, Journal of the American College of Cardiology.
[19] Katherine C. Wu,et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[20] Craig J. Hartley,et al. A novel feature-tracking echocardiographic method for the quantitation of regional myocardial function: validation in an animal model of ischemia-reperfusion. , 2008, Journal of the American College of Cardiology.
[21] Karen A. Hartman,et al. Troponin, B‐type natriuretic peptides and outcomes in severe heart failure: Differences between ischemic and dilated cardiomyopathies , 2007, Clinical cardiology.
[22] Dudley J Pennell,et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[23] Barry J Maron,et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.
[24] P. Sengupta,et al. Two-dimensional strain--a Doppler-independent ultrasound method for quantitation of regional deformation: validation in vitro and in vivo. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[25] C H Lorenz,et al. Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.
[26] D. Schaid,et al. Progression of familial and non-familial dilated cardiomyopathy: long term follow up , 2003, Heart.
[27] B. Wandt. Long-axis contraction of the ventricles: a modern approach, but described already by Leonardo da Vinci. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[28] R H Hruban,et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.
[29] W. Mckenna,et al. The pathophysiology of advanced heart failure. , 1998, Heart & lung : the journal of critical care.
[30] B Maisch,et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.
[31] J. Dumesnil,et al. A Mathematical Model of the Dynamic Geometry of the Intact Left Ventricle Its Application to Clinical Data , 1979, Circulation.